Glenmark Pharmaceuticals Ltd

BSE Code : 532296
NSE Symbol : GLENMARK
ISIN : INE935A01035
Industry :PHARMACEUTICALS - INDIAN - BULK DRUGS & FORMLN

Trade Now

Get Quotes

2,091.80 -9.30(-0.44%)

Open Price (₹)

2,085.00

Prev. Close (₹)

2,101.10

Volume (No’s)

970,078

Market Cap (₹)

59,030.77

Low Price (₹)

1,966.50

High Price (₹)

2,098.40

Chart

Technical Chart

Corparate Information

Financials

Corporate Action

Profit and Loss

	Mar 2025 (₹.Cr)	Mar 2024 (₹.Cr)	Mar 2023 (₹.Cr)	Mar 2022 (₹.Cr)	Mar 2021 (₹.Cr)	Mar 2020 (₹.Cr)
INCOME :
Sales Turnover	9,226.41	7,891.12	8,220.66	8,141.58	7,567.93	6,712.63
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	9,226.41	7,891.12	8,220.66	8,141.58	7,567.93	6,712.63
Other Income	356.37	6,238.36	985.94	1,044.96	470.13	625.34
Stock Adjustments	-44.48	103.07	31.37	16.13	-5.24	-48.77
Total Income	9,538.30	14,232.55	9,237.97	9,202.67	8,032.82	7,289.20
EXPENDITURE :
Raw Materials	3,154.65	3,313.19	3,427.07	3,425.06	2,944.53	2,617.22
Power & Fuel Cost	114.62	104.92	95.09	91.34	80.49	90.76
Employee Cost	1,603.50	1,434.78	1,346.51	1,193.20	1,107.40	1,072.33
Other Manufacturing Expenses	372.36	375.32	304.66	347.04	267.26	230.03
Selling & Administrative Expenses	1,305.30	1,199.17	1,246.10	1,062.89	914.37	977.77
Miscellaneous Expenses	566.49	325.15	855.71	349.97	358.30	371.53
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	7,116.92	6,752.52	7,275.13	6,469.50	5,672.35	5,359.63
Operating Profit	2,421.38	7,480.02	1,962.84	2,733.18	2,360.47	1,929.57
Interest	48.73	277.11	206.82	236.04	265.90	256.39
Gross Profit	2,372.65	7,202.91	1,756.02	2,497.14	2,094.57	1,673.18
Depreciation	218.63	202.16	184.15	159.70	150.82	138.54
Profit Before Tax	2,154.02	7,000.75	1,571.87	2,337.44	1,943.75	1,534.64
Tax	316.09	1,049.99	386.93	411.08	343.62	269.24
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	227.58	783.46	-23.83	-71.42	-49.31	-89.14
Reported Net Profit	1,610.35	5,167.29	1,208.77	1,997.79	1,649.45	1,354.55
Extraordinary Items	-133.98	3,742.26	-369.56	354.02	59.87	14.43
Adjusted Net Profit	1,744.33	1,425.03	1,578.33	1,643.77	1,589.58	1,340.12
Adjustment below Net Profit	-6.47	-4.76	0.63	1.61	2.48	-5.42
P & L Balance brought forward	21,088.13	16,002.82	14,863.96	12,921.86	11,340.47	10,059.38
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	110.87	77.22	70.54	57.30	70.54	68.04
P & L Balance carried down	22,581.15	21,088.13	16,002.82	14,863.96	12,921.86	11,340.47
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	250.00	250.00	250.00	250.00	250.00	250.00
Dividend Per Share(Rs)	2.50	2.50	2.50	2.50	2.50	2.50
Earnings Per Share-Unit Curr	57.07	183.11	42.84	70.80	58.46	48.00
Earnings Per Share(Adj)-Unit Curr	57.07	183.11	42.84	70.80	58.46	48.00
Book Value-Unit Curr	868.35	814.01	633.57	593.21	524.84	468.73
Book Value(Adj)-Unit Curr	868.35	814.01	633.57	593.21	524.84	468.73